It's an exciting time for research into high-risk neuroblastoma. Over the past year, multiple trials testing new treatments showed promising results, and in 2024, new trials are expected to open to ...
Socius and Aviva staff are fundraising for the ICR after the companies joined the partnership at The London Cancer Hub in ...
Scientists have uncovered a promising treatment strategy for an aggressive type of leukaemia – through targeting the enzymes ...
Scientists have discovered how skin cancer cells shapeshift based on their environment – enabling them to spread through the ...
The Institute of Cancer Research, London, is honoured to be a beneficiary of a motorbike ride in tribute to Dave Myers of the ...
The US Food and Drug Administration (FDA) has approved the AKT inhibiting drug capivasertib, now given the brand name Truqap, as a breast cancer treatment. Henry French introduces other current ...
Since its release in 2011, canSAR has become the largest, public, cancer drug discovery resource in the world. Juanita Bawagan takes a look at how it’s enabling the future of drug discovery. Image: 3D ...
Image: Pritpal and her husband Rajinder. Credit: 'Ageing Better' I was a fit and healthy woman until I was diagnosed with myeloma in 2023. I’m 73, and three years ago I learnt how to hula hoop! My ...
Our scientists are developing new ways of diagnosing and treating diverse types of blood cancers, including myeloma, which develops in the bone marrow and accounts for 15 per cent of blood cancers.
Our scientists are developing new ways of diagnosing and treating diverse types of blood cancers, including myeloma, which develops in the bone marrow and accounts for 15 per cent of blood cancers.
The ICR was recently awarded a Queen’s Anniversary Prize in recognition of its transformational work in breast cancer research. Isy Godfrey spoke with two scientists who had recently attended the ...
The ICR was recently awarded a Queen’s Anniversary Prize in recognition of its transformational work in breast cancer research. Isy Godfrey spoke with two scientists who had recently attended the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results